ATIN — Athanase Innovation AB Income Statement
0.000.00%
Last trade - 00:00- SEK343.50m
- SEK43.31m
- SEK115.27m
- 45
- 28
- 13
- 15
Annual income statement for Athanase Innovation AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 June 30th | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 42.4 | 7.06 | 6.38 | 19.3 | 115 |
| Cost of Revenue | |||||
| Gross Profit | 41.4 | — | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 34.1 | 37.4 | 130 | 86.5 | 135 |
| Operating Profit | 8.3 | -30.3 | -124 | -67.2 | -19.6 |
| Net Income Before Taxes | 8.3 | -30.3 | -124 | -67.2 | -19.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.19 | -26.6 | -115 | -56.3 | -19.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.19 | -26.6 | -115 | -56.3 | -19.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6.19 | -26.6 | -115 | -56.3 | -19.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 33 | -0.489 | -3.69 | -1.88 | -0.575 |
| Dividends per Share |